>> 全站文章索引 >> 第36页:
Paroxetine for the prevention of depression induced by high-dose interferon alpha - [Dominique L Musselman, David H Lawson, Jane F Gumnick, Amita K Manatunga, et al]
Effects of paroxetine on cardiovascular response to mental stress in subjects with a history of coronary artery disease and no psychiatric diagnoses - [Golding M, Kotlyar M, Carson SW, Hoyler S, Lazarus C, Davidson C, Guzzo J, Sontz E, Garbutt JC]
Synthesis of the major metabolites of Paroxetine - [Mireia Segura, Lidia Roura, Rafael de la Torre and Jesús Joglar]
Analysis of sleep EEG microstructure in subchronic paroxetine treatment of healthy subjects - [J. R?schke, P. K?gel, R. Schl?sser, P. Wagner, K. Mann, W. Rossbach, O. Benkert]
Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review - [Michel Bourin 1 2 * AD:1Neurobiology of Anxiety and Depression, Faculty of Medicine, Nantes, France2Neurochemical Research Unit, University of Alberta, Edmonton, Alberta, Canada]
Mirtazapine and paroxetine: a drug-drug interaction study in healthy subjects - [F. J. L. Ruwe 1, R. A. Smulders 3, H. J. Kleijn 2, H. L. A. Hartmans 3, J. M. A. Sitsen 1 * AD:1Clinical Development Department, NV Organon, PO Box 20, 5340 BH Oss, The Netherlands2Department of Drug Metabolism & Kinetics, NV Organon, PO Box 20, 5340 BH O]
Breast cancer risk in a large cohort of female antidepressant medication users - [Reina Haque, Shelley M. Enger, Wansu Chen and Diana B. Petitti]
The Effect of Paroxetine and Dothiepin on Subjective Sleep in Depressed Patients - [JOHN S. KERR *, DIANE B. FAIRWEATHER, IAN HINDMARCH AD:HPRU, University of Surrey, Milford Hospital, Godalming, Surrey, GU7 1UF, UK]
Asymmetric synthesis of (-)-paroxetine using PLE hydrolysis - [Marvin S. Yu, Ivan Lantos, Zhi-Qiang Peng, J. Yu and Thomas Cacchio]
Paroxetine in Child and Adolescent Outpatients with Panic Disorder - [Gabriele Masi, Cristina Toni, Maria Mucci, Stefania Millepiedi, Belen Mata, Giulio Perugi]
Paroxetine in panic disorder-clinical management and long-term follow-up C - [Dannon PN, Lowengrub K, Iancu I, Kotler M.]
Changes in lymphocyte subsets after short-term pharmacotherapy in patients with panic disorder - [Youl-Ri Kim, Quehn Park and Bum-Hee Yu]
Treatment of Panic Disorder focus on Paroxetine - [Pollack MH, Doyle AC.]
Panic disorder subtypes further clinical differencessup?-sup - [Onur E, Alk?n T, Tural U.]
Mitochondrial complex I Structure, function and pathology - [Janssen RJ, Nijtmans LG, van den Heuvel LP, Smeitink JA.]
Quality of life for patients with epithelial ovarian cancer - [Sun CC, Ramirez PT, Bodurka DC.]
Paroxetine treatment of compulsive hoarding - [Sanjaya Saxena, Arthur L. Brody, Karron M. Maidment and Jr., Lewis R. Baxter]
Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine - [John Greist, Robert K. McNamara, Craig H. Mallinckrodt, Jyoti N. Rayamajhi and Joel Raskin]
Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine - [Kazushi Sawamura, Yutaro Suzuki, Toshiyuki Someya]
The effects of Guillain–Barré syndrome on the close relatives of patients during the of patients during the first year - [Bernsen RA, de Jager AE, van der Meché FG, Suurmeijer TP.]
Cerebro- and cardiovascular conditions in adults with schizophrenia treated with antipsychotic medications - [Jerrell JM, McIntyre RS]
Cerebro- and cardiovascular conditions in adults with schizophrenia treated with antipsychotic medications - [Jerrell JM, McIntyre RS]
8-OH-DPAT, but not deramciclane, antagonizes the anxiogenic-likeaction of paroxetine in an elevated plus-maze - [Sulev K?ks, Sergei Beljajev, Indrek Koovit, Urho Abramov, Michel Bourin, Eero Vasar]
On-Demand Treatment of Premature Ejaculation with Clomipramine and Paroxetine: A Randomized, Double-Blind Fixed-Dose Study with Stopwatch Assessment - [Marcel D. Waldinger, Aeilko H. Zwinderman and Berend Olivier]
Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline. - [Modell JG, Katholi CR, Modell JD, DePalma RL.]
Childhood Anxiety in a Diverse Primary Care Population-Parent-Child Reports, Ethnicity and SCARED Factor Structure - [Wren FJ, Berg EA, Heiden LA, Kinnamon CJ, Ohlson LA, Bridge JA, Birmaher B, Bernal MP.]
Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia - [Malhi GS, Ivanovski B, Hadzi-Pavlovic D, Mitchell PB, Vieta E, Sachdev P.]
Does dopamine dysfunction drive depression - [Malhi GS, Berk M.]
Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding population based case-control study - [de Abajo FJ, Rodríguez LA, Montero D.]
Family Caregivers of Stroke Survivors: Characteristics of Caregivers at Risk for Depression - [Grant, Joan S.; Weaver, Michael; Elliott, Timothy R.; Bartolucci, Alfred A.; Giger, Joyce Newman]
Use of “2-dose” regimen of methotrexate to treat ectopic pregnancy - [Barnhart K, Hummel AC, Sammel MD, Menon S, Jain J, Chakhtoura N.]
The effect of surgery on quality of life in patients with faecal incontinence of obstetric origin - [Pla-Martí V, Moro-Valdezate D, Alos-Company R, Solana-Bueno A, Roig-Vila JV.]
Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trial - [Pinhas N. Dannon, Yehuda Sasson, Shmuel Hirschmann, Iulian Iancu, Leon J. Grunhaus and Joseph Zohar]
Case report of two Persian Gulf War veterans with citalopram - [Khouzam HR, el-Gabalawi F, Donnelly NJ]
Depressive symptoms after stroke and relationship with dementia - [Verdelho, A. MD; Henon, H. MD; Lebert, F. MD; Pasquier, F. MD; Leys, D. MD]
Screening for generalized anxiety disorder in geriatric primary care patients - [Wetherell JL, Birchler GD, Ramsdell J, Unützer J]
Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults - [M. Philipp, J. W. G. Tiller, D. Baier and R. Kohnen]
Effectiveness of liaison psychiatric nursing in older medical inpatients with depression a randomised controlled trial - [Cullum S, Tucker S, Todd C, Brayne C.]
Assessing disability and quality of life in systemic sclerosis - [Rannou F, Poiraudeau S, Berezné A, Baubet T, Le-Guern V, Cabane J, Guillevin L, Revel M, Fermanian J, Mouthon L.]
Psychotropic drug utilization in Europe results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project - [Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lépine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonel]
Early-life risk factors for late-onset depression - [Sneed JR, Kasen S, Cohen P.]
Early-life rist factors for late-onset depression - [Sneed JR, Kasen S, Cohen P.]
The Internalising and Externalising Dimensions of Affective Symptoms in Depressed (Unipolar) and Bipolar Patients - [Bech P, Hansen HV, Kessing LV.]
Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. - [Ballenger JC, Wheadon DE, Steiner M, Bushnell W, Gergel IP]
Randomized, placebo-controlled trial of paroxetine versus imipramine in depressed hiv-positive outpatients - [Andrew J Elliott; Karina K Uldall; Karen Bergam; Joan Russo; et al]
Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study. - [Marshall RD, Beebe KL, Oldham M, Zaninelli R]
Bipolar Depression in a Low-Income Primary Care Clinic - [Olfson M, Das AK, Gameroff MJ, Pilowsky D, Feder A, Gross R, Lantigua R, Shea S, Weissman MM.]
Sertraline in the treatment of panic disorder A double-blind multicenter trial - [Pohl RB, Wolkow RM, Clary CM.]
Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease - [J Craig Nelson, John S Kennedy, Bruce G Pollock, Fouzia Laghrissi-Thode, et al]
Nortriptyline Versus Fluoxetine in the Treatment of Depression and in Short-Term Recovery After Stroke: A Placebo-Controlled, Double-Blind Study - [Robinson, Robert G.; Schultz, Susan K.; Castillo, Carlos M.; Kopel, Teresa M.; Kosier, J. Todd; Newman, R. Mark; Curdue, Kathryn M.; Petracca, Gustavo M.; Starkstein, Sergio E.]
The Crucial Role of Frontostriatal Circuits for Depressive Disorders in the Postacute Stage After Stroke - [Beblo, Thomas Ph; Wallesch, Claus W.; Herrmann, Manfred M.]
Rational treatment choices for non-major depressions in primary care an evidence-based review - [Ackermann RT, Williams JW.]
- [Robert Wood Johnson Clinical Scholars Program, University of Washington, Veterans Affairs Puget Sound Health Care System, Seattle, Wash, USA.]
Sexual functioning in chronically depressed patients treated with SSRI antidepressants: a pilot study. - [Piazza LA, Markowitz JC, Kocsis JH, Leon AC, Portera L, Miller NL, Adler D]
Eszopiclone, a Nonbenzodiazepine Sedative-Hypnotic Agent for the Treatment of Transient and Chronic Insomnia - [Najib J.]
Disability and quality of life impact of mental disorders in Europe results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project - [Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lépine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonel]
双相障碍的增长趋势 - [Xu J, Rasmussen IA, Berntsen EM, Moss K, Shnier R, Lagopoulos J, Malhi GS.]
广泛性焦虑障碍：一个 40 年回顾性研究 - [Rubio G, López-Ibor JJ.]
Epidemiology of subtypes of depression - [Kessing LV.]
An Open-Label Study of Lamotrigine Adjunct or Monotherapy for the Treatment of Adolescents With Bipolar Depression - [Chang K, Saxena K, Howe M.]
Cerebral glucose metabolic response to combined total sleep deprivation and antidepressant treatment in geriatric depression. - [Smith GS, Reynolds CF 3rd, Pollock B, Derbyshire S, Nofzinger E, Dew MA, Houck PR, Milko D, Meltzer CC, Kupfer DJ]
Treatment of dysthymia and minor depression in primary care a randomized trial in patients aged 18 to 59 - [Barrett JE, Williams JW, Oxman TE, Frank E, Katon W, Sullivan M, Hegel MT, Cornell JE, Sengupta AS.]
Treatment of dysthymia and minor depression in primary care: a randomized trial in patients aged 18 to 59 years.[see comment] - [Department of Community and Family Medicine, Dartmouth Medical School, Hanover, NH 03755, USA. James.Barrett@Dartmouth.edu]
Effectiveness of Olanzapine, Quetiapine, and Risperidone in Patients With Chronic Schizophrenia After Discontinuing Perphenazine - [Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Capuano GA, Rosenheck RA, Keefe RS, Miller AL, Belz I, Hsiao JK; CATIE Investigators.]
Patterns, predictors and impact of substance use in early psychosis a longitudinal study - [Addington J, Addington D]
Effect of pindolol on onset of action of paroxetine in the treatment of major depression: intermediate analysis of a double-blind, placebo-controlled trial - [Bordet R, Thomas P, Dupuis B]
Paroxetine in human breast milk and nursing infants. - [Stowe ZN, Cohen LS, Hostetter A, Ritchie JC, Owens MJ, Nemeroff CB]
A Randomized Controlled Clinical Trial of Psychoanalytic psychotherapy for panic disorder - [Milrod B, Leon AC, Busch F, Rudden M, Schwalberg M, Clarkin J, Aronson A, Singer M, Turchin W, Klass ET, Graf E, Teres JJ, Shear MK.]
Prevalence and predictors of depression treatment in an international primary care study - [Dr. G.E. Simon, Center for Health Studies, 1730 Minor Ave., Number 1600, Seattle, WA 98101; United States. E-Mail: simon.g@ghc.org.]
Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone1 - [Kinon BJ, Gilmore JA, Liu H, Halbreich UM.]
Correlates of Late-Life Major Depression A Comparison of Urban and Rural Primary Care Patients - [Friedman B, Conwell Y, Delavan RL.]
Medical disorders affect health outcome and general functioning depending on comorbid major depression in the general population - [Baune BT, Adrian I, Jacobi F.]
Symptoms of Depression as a Prospective Risk Factor for Stroke - [Jonas, Bruce S.; Mussolino, Michael E.]
Comorbid personality disorder and treatment use in a community sample of youths a 20-year follow-up - [Kasen S, Cohen P, Skodol AE, First MB, Johnson JG, Brook JS, Oldham JM.]
Sampling and methods of the European Study of the Epidemiology of Mental Disorders (ESEMeD) project - [Alonso J, Angermeyer MC, Bernert S, Bruffaerts R, Brugha TS, Bryson H, de Girolamo G, Graaf R, Demyttenaere K, Gasquet I, Haro JM, Katz SJ, Kessler RC, Kovess V, Lépine JP, Ormel J, Polidori G, Russo LJ, Vilagut G, Almansa J, Arbabzadeh-Bouchez S, Autonel]
Pindolol potentiation of paroxetine for generalized social phobia A double-blind, placebo-controlled, crossover study - [Stein MB, Sareen J, Hami S, Chao J.]
Atypical depression current status and relevance to melancholia - [Stewart JW, McGrath PJ, Quitkin FM, Klein DF]
Selective alteration of personality and social behavior by serotonergic intervention - [Brian Knutson; Owen M Wolkowitz; Steve W Cole; Theresa Chan; et al]
Pharmacogenetics of antidepressant medication intolerance - [Murphy GM, Kremer C, Rodrigues HE, Schatzberg AF.]
Serum anticholinergicity in elderly depressed patients treated with paroxetine or nortriptyline. - [Pollock BG, Mulsant BH, Nebes R, Kirshner MA, Begley AE, Mazumdar S, Reynolds CF 3rd]
Post-Stroke and Clinically-Defined Vascular Depression in Geriatric Rehabilitation Patients. - [Mast BT, MacNeill SE, Lichtenberg PA.]
Post-Stroke and Clinically-Defined Vascular Depression in Geriatric Rehabilitation Patients - [Mast, Benjamin T.; MacNeill, Susan E.; Lichtenberg, Peter A.]
Course and rate of antidepressant response in the very old - [Ariel G. Gildengers, Patricia R. Houck, Benoit H. Mulsant, Bruce G. Pollock, Sati Mazumdar, Mark D. Miller, Mary Amanda Dew, Ellen Frank, David J. Kupfer and Charles F. Reynolds III]
Efficacy and Safety of Extended-Release Venlafaxine in the Treatment of Generalized Anxiety Disorder in Children and Adolescents Two Placebo-Controlled Trials - [Rynn MA, Riddle MA, Yeung PP, Kunz NR.]
Cerebrovascular Disease and Late-Life Depression - [Mast, Benjamin T.]
Evaluation of suicidal thoughts and behaviors in children and adolescents taking paroxetine - [Apter A, Lipschitz A, Fong R, Carpenter DJ, Krulewicz S, Davies JT, Wilkinson C, Perera P, Metz A.]
Clinical features and personality traits associated with psychological distress in systemic sclerosis patients - [Hyphantis TN, Tsifetaki N, Pappa C, Voulgari PV, Siafaka V, Bai M, Alamanos Y, Drosos AA, Mavreas V.]
The Impact of Acupuncture and Craniosacral Therapy Interventions on Clinical Outcomes in Adults With Asthma - [Mehl-Madrona L, Kligler B, Silverman S, Lynton H, Merrell W.]
Sertraline Versus Paroxetine in the Treatment of Panic Disorder An Acute, Double-blind Noninferiority Comparison - [Bandelow B, Behnke K, Lenoir S, Hendriks GJ, Alkin T, Goebel C, Clary CM.]
Prediction of response to paroxetine and venlafaxine by serotonin related genes in obsessive-compulsive disorder - [Denys D, Van Nieuwerburgh F, Deforce D, Westenberg HG.]
Sleep and circadian rhythms in mood disorders - [Armitage R]
The Kutcher Adolescent Depression Scale:Assessment of Its Evaluative Properties over theCourse of an 8-Week Pediatric Pharmacotherapy Trial - [Brooks SJ, Krulewicz SP, Kutcher S.]
Clastogenicity of selective serotonin-reuptake inhibitors - [Gokay Bozkurt, Ercan Abay, Ibrahim Ates, Goksel Karabogaz, Mevlut Ture, Fatma Oguz Savran, Sukru Palanduz, Kubra Temocin and Cetin Algunes]
Antidepressant therapy in tinnitus - [Shannon K. Robinson, Erik S. Viirre and Murray B. Stein]
Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats - [Kishi, Takuya; Hirooka, Yoshitaka; Mukai, Yasushi; Shimokawa, Hiroaki; Takeshita, Akira]
What is the value of treating schizophrenia - [Carr VJ, Lewin TJ, Neil AL]
GABA(A) Receptor-Modulating Neuroactive Steroid Composition in Patients With Panic Disorder Before and During Paroxetine Treatment. - [Strohle A, Romeo E, di Michele, Pasini A, Yassouridis A, Holsboer F, Rupprecht R]
Depression and Other Mental Health Diagnoses Increase Mortality -Risk After Ischemic Stroke - [Williams LS, Ghose SS, Swindle RW.]
Depression and Other Mental Health Diagnoses Increase Mortality Risk After Ischemic Stroke - [Williams, Linda S.; Ghose, Sushmita Shoma; Swindle, Ralph W.]
Depression and Other Mental Health Diagnoses After Stroke Increase Inpatient and Outpatient Medical Utilization Three Years Poststroke - [Ghose, Sushmita Shoma; Williams, Linda S.; Swindle, Ralph W.]
分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 [36] 37 38 39 40
41 42 43 44 45 46 47 48 49 50 |